ARCHIVES

October issue of Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 28 No. 40 | November 2, 2002

Download PDF Visit The Full Archive

Related Articles

HCFA Sees Applications For DRGs And Research

September 27, 1985

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004